RenovoRX
  • Media
  • Careers
  • Investors
  • About
    • Leadership Team
    • Board of Directors
    • Advisory Board
  • Clinical Trials
    • About TIGeR-PaC
    • TIGeR-PaC
      Candidate Criteria
    • TIGeR-PaC Participating
      Clinical Sites
  • Our Therapy Platform
  • Pipeline Overview
  • Clinicians
  • Contact
  • About
    • Leadership Team
    • Board of Directors
    • Advisory Board
  • Clinical Trials
    • About TIGeR-PaC
    • TIGeR-PaC
      Candidate Criteria
    • TIGeR-PaC Participating
      Clinical Sites
  • Our Therapy Platform
  • Pipeline Overview
  • Clinicians
  • News
  • Careers
  • Investors
  • Contact
Investors

Investors

  • Overview
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • News & Events
    • Overview
    • Press Releases
    • Clinical News
    • IR Calendar Events
    • Email Alerts
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents

Press Releases

  • News & Events

  • Overview
  • Press Releases
  • Clinical News
  • IR Calendar Events
  • Email Alerts
May 06, 2025 8:30am EDT

U.S. Patent Office Issues New Patent to RenovoRx for Novel Trans-Arterial Micro-Profusion (TAMP™) Therapy Platform

May 01, 2025 8:30am EDT

RenovoRx to Host First Quarter 2025 Financial Results Conference Call on May 15th at 4:30 p.m. ET

Apr 29, 2025 8:30am EDT

Johns Hopkins Medicine Initiates Patient Enrollment for RenovoRx’s Ongoing Phase III TIGeR-PaC Clinical Trial

Apr 16, 2025 8:30am EDT

RenovoRx Increases U.S. Production of RenovoCath® Devices to Meet Growing Demand from Oncology Community

Apr 04, 2025 8:30am EDT

RenovoRx to Present at LD Micro Invitational XV Conference in New York on April 10th

Apr 01, 2025 8:30am EDT

RenovoRx Reports Initial Revenues from RenovoCath® Commercialization, and Provides Update on Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial

Mar 28, 2025 8:00am EDT

RenovoRx Highlights New Human Pharmacokinetic Data Abstract at SSO 2025 Annual Meeting

Mar 26, 2025 8:00am EDT

RenovoRx Pre-Clinical Results Supporting TAMP™ as a Targeted Locoregional Drug Delivery Platform to Receive Award at SIR 2025 Annual Scientific Meeting

Mar 20, 2025 8:00am EDT

RenovoRx CEO to Provide Strategic Update During Fireside Chat on Thursday, April 3rd at 12:00 p.m. ET

Mar 19, 2025 8:00am EDT

RenovoRx Announces Abstract Presentation at the Society of Surgical Oncology (SSO) 2025

  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 12
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed

2570 W. El Camino Real, Suite 320
Mountain View, CA 94040

(650) 284-4433

(650) 397-4433

RenovoRX

Delivering Therapy Where it Matters

Quicklinks
  • About
  • Clinical Trials
  • Our Therapy Platform
  • Pipeline Overview
  • Clinicians
  • Media
  • Careers
  • Investors
  • Contact

Delivering Therapy Where it Matters

4546 El Camino Real, Suite B1
Los Altos, CA 94022

(650) 284-4433

(650) 397-4433

Quicklinks
  • About
  • Clinical Trials
  • Our Therapy Platform
  • Pipeline Overview
  • Clinicians
  • News
  • Careers
  • Investors
  • Contact

© Copyright 2018-2025 RenovoRx®. All rights reserved. Site by Sheriar Designs.

Privacy Statement | Terms of Use

Menu